GB0113266D0 - Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease - Google Patents
Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung diseaseInfo
- Publication number
- GB0113266D0 GB0113266D0 GBGB0113266.1A GB0113266A GB0113266D0 GB 0113266 D0 GB0113266 D0 GB 0113266D0 GB 0113266 A GB0113266 A GB 0113266A GB 0113266 D0 GB0113266 D0 GB 0113266D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- genes
- proteins
- treatment
- lung disease
- chronic lung
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0113266.1A GB0113266D0 (en) | 2001-05-31 | 2001-05-31 | Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease |
AU2002314114A AU2002314114A1 (en) | 2001-05-31 | 2002-05-28 | Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease |
PCT/EP2002/005835 WO2002097127A2 (en) | 2001-05-31 | 2002-05-28 | Genes and proteins for prevention, prediction, diagnosis, prognosis and treatment of chronic lung disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0113266.1A GB0113266D0 (en) | 2001-05-31 | 2001-05-31 | Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease |
Publications (1)
Publication Number | Publication Date |
---|---|
GB0113266D0 true GB0113266D0 (en) | 2001-07-25 |
Family
ID=9915652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB0113266.1A Ceased GB0113266D0 (en) | 2001-05-31 | 2001-05-31 | Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002314114A1 (en) |
GB (1) | GB0113266D0 (en) |
WO (1) | WO2002097127A2 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0610065A2 (en) | 2005-05-19 | 2010-05-25 | Synergenz Bioscience Ltd | method and kit for determining an individual's risk of developing lung cancer, nucleotide probe and / or primers, nucleic acid microarray, method for selecting compounds that modulate gene expression and / or activity, and evaluation method likely response of an individual to prophylactic or therapeutic treatment |
EP1888779A4 (en) | 2005-05-20 | 2009-06-10 | Synergenz Bioscience Ltd | Methods of analysis of polymorphisms and uses thereof |
CA2636990A1 (en) * | 2006-01-13 | 2007-07-26 | Battelle Memorial Institute | Animal model for assessing copd-related diseases |
US20100119474A1 (en) * | 2007-03-06 | 2010-05-13 | Cornell University | Chronic obstructive pulmonary disease susceptibility and related compositions and methods |
EP3494985B1 (en) * | 2013-09-16 | 2021-02-24 | CeMM - Forschungszentrum für Molekulare Medizin GmbH | Vaccine composition comprising mutant calreticulin |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5955314A (en) * | 1996-11-08 | 1999-09-21 | Incyte Pharmaceuticals, Inc. | Regulator of cell signaling |
US6008017A (en) * | 1997-01-02 | 1999-12-28 | Smithkline Beecham Corporation | Human cardiac/brain tolloid-like protein |
WO1999031271A1 (en) * | 1997-12-16 | 1999-06-24 | Teijin Limited | Analysis of predisposition based on human airway tripsin protease gene polymorphism |
AU3395900A (en) * | 1999-03-12 | 2000-10-04 | Human Genome Sciences, Inc. | Human lung cancer associated gene sequences and polypeptides |
-
2001
- 2001-05-31 GB GBGB0113266.1A patent/GB0113266D0/en not_active Ceased
-
2002
- 2002-05-28 WO PCT/EP2002/005835 patent/WO2002097127A2/en not_active Application Discontinuation
- 2002-05-28 AU AU2002314114A patent/AU2002314114A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002097127A2 (en) | 2002-12-05 |
AU2002314114A1 (en) | 2002-12-09 |
WO2002097127A3 (en) | 2003-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1551990A4 (en) | Diagnosis and treatment of chemoresistant tumors | |
AU2003293460A1 (en) | Novel application of biosensors for diagnosis and treatment of disease | |
EP1581119A4 (en) | Compositions and methods for the therapy and diagnosis of inflammatory bowel disease | |
AU2003297300A8 (en) | Novel gene targets and ligands that bind thereto for treatment and diagnosis of carcinomas | |
AU2003230838A8 (en) | Methods of diagnosing potential for metastasis or developing hepatocellular carcinoma and of identifying therapeutic targets | |
ZA200500882B (en) | Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis of treatment or liver disorders and epithelial cancer | |
EP1516049A4 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
EP1550462A4 (en) | Remedy or preventive for kidney disease and method of diagnosing kidney disease | |
WO2003031650A3 (en) | Genes and proteins for prevention, prediction, prognosis and therapy of cardiovascular disease | |
EP1446013A4 (en) | Compositions and methods for the therapy and diagnosis of lung cancer | |
EP1429775A4 (en) | Methods of treating pulmonary disease | |
GB0113266D0 (en) | Genes and proteins for prevention prediction diagnosis prognosis and treatment of chronic lung disease | |
HUP0303306A3 (en) | Use of il-18 inhibitors for the treatment and/or prevention of heart disease | |
IL164078A0 (en) | Treatment of lung disorder | |
AU2003218208A8 (en) | Methods for diagnosis and prognosis of cancer | |
IL145714A0 (en) | Prediction of risk of interstitial lung disease | |
EP1589980A4 (en) | Methods of diagnosis and treatment of interstitial lung disease | |
HK1090392A1 (en) | Methods for the diagnosis and prognosis of alzheimers disease | |
AU2003228339A8 (en) | Prevention and treatment of disease using angiogenesis-and/or tumor antigens | |
AU2003232022A1 (en) | USE OF PARATHYROID HORMONE-RELATED PROTEIN (PTHrP) IN THE DIAGNOSIS AND TREATMENT OF CHRONIC LUNG DISEASE AND OTHER PATHOLOGIES | |
ZA200501839B (en) | Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor | |
AU2003302462A8 (en) | Bead-based detection of ligand-gpcr-g protein complexes | |
AU2002251367A1 (en) | Proteins and genes for diagnosis and treatment of erbb2-related cancer | |
AU2003263036A8 (en) | Span-xb gene and protein for the diagnosis and treatment of cancer | |
AU2002235924A1 (en) | Cyp46 genotype determination for risk and treatment evaluation of alzheimer's disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |